LAWRENCE DAVID 4
4 · ACORDA THERAPEUTICS INC · Filed Nov 7, 2018
Insider Transaction Report
Form 4
LAWRENCE DAVID
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2018-11-05$20.28/sh−747$15,149→ 6,146 total
Footnotes (1)
- [F1]Reflects the number of shares of the issuer's Common Stock that were withheld to cover tax liability in connection with settlement of restricted stock units that vested as reported on a prior Form 4.